IRONWOOD INVESTMENT MANAGEMENT LLC - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 178 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
IRONWOOD INVESTMENT MANAGEMENT LLC ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$2,378,000
-15.7%
191,170
-7.2%
1.74%
-19.9%
Q3 2016$2,820,000
+30.1%
206,010
-29.8%
2.17%
+33.4%
Q2 2016$2,168,000
+4.5%
293,352
-9.6%
1.62%
+19.6%
Q1 2016$2,074,000
-29.6%
324,636
-31.2%
1.36%
+11.7%
Q4 2015$2,947,000
-13.0%
471,516
-18.7%
1.22%
-2.2%
Q3 2015$3,386,000
-46.5%
579,719
-24.3%
1.24%
-14.6%
Q2 2015$6,330,000
-24.0%
765,415
-24.3%
1.46%
-5.6%
Q1 2015$8,330,000
+18.9%
1,010,864
-0.8%
1.54%
+20.8%
Q4 2014$7,003,000
+94.1%
1,019,324
+52.5%
1.28%
+95.6%
Q3 2014$3,608,000
-9.7%
668,220
+6.5%
0.65%
+2.5%
Q2 2014$3,997,000
-19.7%
627,480
+1.6%
0.64%
-11.8%
Q1 2014$4,976,000
+20.8%
617,387
+2.2%
0.72%
+26.0%
Q4 2013$4,119,000
-61.2%
603,949
+4.6%
0.57%
-65.6%
Q3 2013$10,620,000
+7.3%
577,195
+2.0%
1.67%
-5.1%
Q2 2013$9,899,000565,9561.76%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$175,916,00040.51%
Consonance Capital Management LP 8,695,742$119,045,00011.46%
Tamarack Advisers, LP 3,700,000$49,358,0007.76%
Opaleye Management Inc. 1,045,000$14,306,0007.49%
Granite Point Capital Management, L.P. 457,415$6,262,0002.44%
Redmile Group, LLC 2,138,471$29,276,0002.33%
IRONWOOD INVESTMENT MANAGEMENT LLC 206,010$2,820,0002.17%
Palo Alto Investors LP 2,587,617$35,424,0002.06%
PRICE MICHAEL F 940,000$12,869,0001.71%
HighVista Strategies LLC 638,086$8,735,0001.62%
View complete list of ARIAD PHARMACEUTICALS INC shareholders